Live News EQUITY FLASH M impact Nov 17, 2026, 08:55 AM UTC AstraZeneca Secures US and EU Approvals for Klygefa AstraZeneca’s rare disease unit secured US and EU approvals for Klygefa for myasthenia gravis. AZN SquawkNews Desk